Telethon Institute for Child Health Research   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Perth Australia (1990)

Organization Overview

First Clinical Trial
1998
NCT00003291
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Telethon Kids Institute, Perth

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Bacteremia (Phase 3)

Cystic Fibrosis (Phase 3)

Fibrosis (Phase 3)

Meningitis (Phase 3)

Otitis Media (Phase 3)

Pneumonia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 8